Cargando…
Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer
BACKGROUND: Surgical tumor resection is the only potentially curative treatment option for patients with biliary tract cancer (BTC). However, 5-year survival rates are still below 50% mainly due to tumor recurrence. The preoperative identification of ideal surgical candidates has remained a major ch...
Autores principales: | Roderburg, Christoph, Labuhn, Simon, Bednarsch, Jan, Lang, Sven A., Schneider, Anne T., Hammerich, Linda, Vucur, Mihael, Ulmer, Tom F., Neumann, Ulf P., Luedde, Tom, Loosen, Sven H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731746/ https://www.ncbi.nlm.nih.gov/pubmed/36505756 http://dx.doi.org/10.1155/2022/6195004 |
Ejemplares similares
-
Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer
por: Loosen, Sven H., et al.
Publicado: (2022) -
Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
por: Loosen, Sven H., et al.
Publicado: (2022) -
Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC
por: Loosen, Sven H., et al.
Publicado: (2021) -
Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma
por: Roderburg, Christoph, et al.
Publicado: (2021) -
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer
por: Loosen, Sven H., et al.
Publicado: (2020)